Chapter 545 A Stopgap Plan

• Zenith Pharmaceuticals is worth around 15 to 16 billion in total, with only 2 to 3 billion in cash flow on a normal day. This time, to get the exclusive formula and the mature production equipment and tech from Wellness Pharmaceutical Group’s branch, Chairman Wainwright prepared ahead of time and scraped together 5 billion. For Zenith, that was clearly the limit.
• But plans look perfect on paper; reality cuts to the bone. Thanks to Finnian’s interference, Zenith burned roughly an extra 2 billion quietly buying up shares. What was left wasn’t enough to purchase the shares in Mr. Xander’s hands.
• “Ten billion won’t cut it. Cash in one hand, shares in the other. If your company can’t put up thirty billion, I’m not handing over the equity,” Mr. Xander said with a shake of his head.